SunBird Bio, Inc. — Form D

SunBird Bio, Inc. of CAMBRIDGE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2021-12-17. The offering totals $18.0M, of which $18.0M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (24)

NameRoleLocation
Francis CussDirectorCambridge, MA
Theresia GouwDirectorSan Francisco, CA
Robert LangerDirectorPittsburgh, PA
Caroline LoewDirectorBoston, MA
Amy SchulmanDirectorCambridge, MA
George ZacharyDirectorSan Francisco, CA
Wendy Winckler AdamovichExecutive OfficerCambridge, MA
Jessica Winckler AtkinsonExecutive OfficerCambridge, MA
Dhaval Winckler GosaliaExecutive OfficerCambridge, MA
Caroline LoewExecutive OfficerBoston, MA
Matthew Winckler NavarroExecutive OfficerCambridge, MA
Tram Winckler TranExecutive OfficerCambridge, MA
Alexandra CantleyDirectorNewton, MA
Stanley LapidusDirectorBOSTON, MA
Steve KafkaDirectorSan Mateo, CA
John McDonoughDirectorNew York, NY
Sirshendu Roopom BanerjeeExecutive OfficerWoburn, MA
YINGMIN WANGDirectorCAMBRIDGE, MA
HUILIN SHAODirectorCAMBRIDGE, MA
Tracey DawsonExecutive OfficerCambridge, MA
Theresia Roopom GuowDirectorCambridge, MA
Gabriel KwongExecutive OfficerCambridge, MA
Stan Roopom LapidusDirectorCambridge, MA
Amy Roopom SchulmanDirectorCambridge, MA

Other filings by this issuer (4)

FiledFormOfferingSold
2023-05-12D$23.2M$23.2M
2021-07-01D/A$46.7M$46.7M
2020-06-12D$45.0M$26.1M
2018-08-06D$30.1M$26.1M

More